The initial pivotal studies that led to the first wave of GLP-1 RAs demonstrated that they work in several ways, including stimulating insulin release, slowing digestion, reducing appetite, and inhibiting glucagon release
The Food and Drug Administration (FDA) approved the medication to treat type 2 diabetes but health care providers also prescribe it off-label (uses other than originally intended) for the treatment of obesity or to help with weight management
Common Side Effects The most common side effects are nausea, bloating, vomiting, diarrhea, constipation, and early fullness
JAMA 318(15):14601470
Dietary supplementation with zinc oxide increases Igf-I and Igf-I receptor gene expression in the small intestine of weanling piglets
Tummy Tuck: Key Differences Explained Originally Published March 12, 2014